Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
N6-Methyladenosine (M6a) Rna Modification’S Regulatory Role in Acute and Chronic Leukemia Publisher



Majidi Z1 ; Mohammadyari P2 ; Khatib ZK2 ; Alizadeh S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Laboratory Science, School of Allied Medicine Science, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Hematology and Transfusion Medicine, School of Allied Medicine Science, Tehran University of Medical Sciences, Tehran, Iran

Source: Gene Expression The Journal of Liver Research Published:2025


Abstract

Hematological malignancies present a complex challenge within oncology, necessitating a thorough understanding of genetic factors for effective detection and management. As we delved into the forefront of cancer research, our focus turned to the emerging field of N6-methyladenosine (m6A) epigenetic approaches. Among RNA modifications, m6A is the most common and thoroughly investigated post-transcriptional alteration in messenger RNA. The m6A modification involves the addition of a methyl group to the adenosine at the N6 position within RNA molecules, a process mediated by proteins collectively referred to as m6A writers, erasers, and readers. The dynamic nature of m6A modifications on RNA molecules presents a promising avenue for enhancing our understanding of gene expression regulation in hematological malignancies. This review explores the potential breakthroughs that m6A epigenetic tools offer in cancer diagnostics and treatment, highlighting their role in enabling more precise interventions. By acknowledging the importance of genetic insights and integrating advancements in m6A epigenetics, this article advocates for a comprehensive approach to managing hematological malignancies. © 2025 The Author(s).
Related Docs
Experts (# of related papers)